STREPTAMER

Welcome to the Brand page for “STREPTAMER”, which is offered here for Pharmaceutical, medical and veterinary preparations, polypeptides and proteins produced by genetic engineering, including fusion proteins, and body cells and cells of the immune system of mammals, all used for the treatment of graft rejections and/'or viral infections and/or cancer by providing functional, antigen specific t cells for adoptive transfer, for the monitoring of the functional t cell status after vaccinations; medical diagnostic reagents;chemicals used in biopharmaceutical industry and science for the isolation of body cells and cells of the immune system of mammals, for scientific, medical or laboratory research; diagnostic reagents for scientific or research use; analytic kits comprising streptavidin or streptavidin muteins carrying a fluorescent and/or magnetic label and/or recombinant mhc i or mhc ii molecules fused to an affinity label, binding to such labeled streptavidin or streptavidin muteins, used for the isolation of t cells under maintenance of their authentic properties;[scientific and industrial research in the fields of biochemistry, medical diagnostics and pharmaceuticals; biochemical and pharmaceutical laboratory services featuring the synthesis of recombinant polypeptides and proteins, cultivator and purification of cells and cells of the immune system of mammals including human cells];.

Its status is currently believed to be active. Its class is unavailable. “STREPTAMER” is believed to be currently owned by “IBA GMBH”.